Fresh analysis suggests that patients who discontinue blockbuster weight-loss injections like Mounjaro or Wegovy tend to recover lost weight far faster than those who stop traditional lifestyle plans.
Findings released in a major health publication shows that while overweight individuals frequently drop about a fifth of their total mass while on the medication, the mass returns at an estimated rate of 0.8 kg per month after stopping.
"Individuals using such treatments must be informed of the risk of rapid weight regain when the medication concludes," cautioned researcher Dr. Susan Jebb.
That rate of regain implies a return to original weight within about one and a half years.
Analyzing Therapies
The research, which looked at dozens of trials involving thousands of patients, compared the effects of these new drugs with older methods.
Researchers emphasize that people who shed pounds through dieting generally have a slower creep back—approximately 100 grams monthly—once they finish.
The Reason for the Quick Rebound
Experts believe the mechanism of the drugs explains the accelerated regain.
The injections mimic a body's own chemical called GLP-1, which controls feelings of fullness.
"Long-term administration of GLP-1 concentrations several times higher than the body's typical production might result in the system to produce less of its own natural hormone, and could lessen responsiveness to its actions," said Dr. Adam Collins, a dietetics expert.
"Discontinuation of this hormone supplement results in appetite is no longer kept in check, making excessive eating much more probable."
An Ongoing Condition?
Medical guidelines suggest the injections for people with obesity-related medical conditions, alongside prescribed diet and exercise modifications.
Many experts say that, given the high risk of weight regain, the treatment should be considered long-term.
This opinion is reinforced by pharmaceutical companies, who say that the findings "emphasize the long-term nature of obesity," similar to managing diseases like high blood pressure.
User Accounts
Individuals who have come off the medication describe a powerful resurgence of cravings.
"I experienced something flipping and you're instantly extremely hungry," described one woman.
This difficulty is compounded if patients have not developed permanent lifestyle or habit modifications during treatment.
Significant Adoption
Survey data suggest that a significant number of adults in the UK have tried weight-loss jabs in the past year, with desire continuing to grow.
- Adoption is more common among women than males.
- The middle-aged demographic shows the highest usage rates.
- Many access the drugs through private healthcare rather than public health services.
In conclusion, clinicians caution that while these medications are effective tools for shedding pounds, they are not a standalone cure and long-term success relies on ongoing behavioural management.
